We are live on ! Find out more
FBLG icon

FibroBiologics
FBLG

52 hedge funds and large institutions have $3.28M invested in FibroBiologics in 2025 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 20 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.14% less ownership

Funds ownership: 0.78% → 0.64% (-0.14%)

9% less funds holding

Funds holding: 57 → 52 (-5)

12% less capital invested

Capital invested by funds: $3.75M → $3.28M (-$467K)

38% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 13

55% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 20

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
52
Holders Change
-5
Holders Change %
-8.77%
% of All Funds
0.68%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
8
Increased
9
Reduced
20
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
LCM
Landscape Capital Management
New Jersey
+$210K
2
GS
GTS Securities
New York
+$185K
3
Renaissance Technologies
Renaissance Technologies
New York
+$35.8K
4
P
&Partners
Tennessee
+$18K
5
LM
Luminus Management
Texas
+$15.9K

Top Sellers

Rank Fund Capital Flow
1
YAG
Yorkville Advisors Global
New Jersey
-$200K
2
BlackRock
BlackRock
New York
-$186K
3
Goldman Sachs
Goldman Sachs
New York
-$72.5K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$66K
5
Jane Street
Jane Street
New York
-$59.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
EFG
26
Ethos Financial Group
Pennsylvania
$13.3K -$14.6K -1,221 -50%
Raymond James Financial
27
Raymond James Financial
Florida
$10.2K – – –
Cetera Investment Advisers
28
Cetera Investment Advisers
Illinois
$9.84K -$599 -50 -5%
LPL Financial
29
LPL Financial
California
$9.6K +$2.99K +250 +40%
TRCT
30
Tower Research Capital (TRC)
New York
$9.27K +$1.04K +87 +11%
NA
31
NewEdge Advisors
Louisiana
$9.23K -$3.59K -300 -26%
CWM
32
Cahaba Wealth Management
Georgia
$8.03K – – –
FAM
33
Flaharty Asset Management
Florida
$8.03K – – –
BIG
34
Brooklyn Investment Group
New York
$7.11K – – –
GAA
35
Global Assets Advisory
Florida
$5.84K +$6.41K +535 New
Goldman Sachs
36
Goldman Sachs
New York
$5.72K -$72.5K -6,054 -92%
CAMG
37
CWA Asset Management Group
Florida
$5.46K +$5.99K +500 New
RCA
38
Runnymede Capital Advisors
Ohio
$5.46K +$5.99K +500 New
Osaic Holdings
39
Osaic Holdings
Arizona
$4.82K – – –
ICM
40
Islay Capital Management
Texas
$1.85K +$1.76K +147 +639%
GBT
41
Grove Bank & Trust
Florida
$1.09K – – –
Royal Bank of Canada
42
Royal Bank of Canada
Ontario, Canada
$1K +$72 +6 +6%
BNP Paribas Financial Markets
43
BNP Paribas Financial Markets
France
$713 -$251 -21 -24%
Fidelity Investments
44
Fidelity Investments
Massachusetts
$655 -$1.26K -105 -64%
AF
45
Allworth Financial
California
$143 – – –
Wells Fargo
46
Wells Fargo
California
$109 -$311 -26 -72%
EWA
47
EverSource Wealth Advisors
Alabama
$28 -$36 -3 -50%
Optiver Holding
48
Optiver Holding
Netherlands
$14 +$12 +1 New
Deutsche Bank
49
Deutsche Bank
Germany
$10 – – –
Morgan Stanley
50
Morgan Stanley
New York
$7 -$3.7K -309 -100%
1
2
3

FBLG Hedge Fund Activity: Q3 2025 in Review

52 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in FibroBiologics (FBLG) for Q3 2025, worth a combined $3.28M — down 12% from $3.75M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of FBLG and 8 opened new positions — a net loss of 5 holders — while 20 trimmed existing stakes and 9 added.

The largest buyer was Landscape Capital Management, opening a new position worth an estimated $210K. The largest seller was Yorkville Advisors Global, cutting an estimated $200K.

  • 52 institutional investors held FibroBiologics (FBLG) as of Q3 2025, down from 57 in Q2 2025.
  • Funds reported $3.28M of FibroBiologics stock for Q3 2025, down 12% quarter-over-quarter.
  • 8 funds opened new FibroBiologics positions in Q3 2025 and 13 closed out, a net change of -5 holders.
  • The largest FibroBiologics buyer in Q3 2025 was Landscape Capital Management, an estimated $210K added.
  • The largest FibroBiologics seller in Q3 2025 was Yorkville Advisors Global, an estimated $200K sold.

Based on aggregated 13F filings for Q3 2025.